The first Covid-19 vaccine may well be Swiss. In any case, researchers at the University of Bern hope that they can produce it by October, reports Swissinfo.ch.
In an online conference with the Association of United Nations Accredited Correspondents (ACANU), the head of the Department of Immunology at the University of Bern Martin Bachmann said that they had “a realistic chance of succeeding” .
Different approach
Unlike other laboratories that use the virus itself, the Swiss team has opted for a different approach. Researchers work with so-called virus-like particles that are not infectious. The result is a serum that offers a good immune response and has already proven its effectiveness in tests on mice in February.
Also according to Swissinfo.ch, Swissmedic, the institute responsible for monitoring the market for therapeutic products in Switzerland, is closely monitoring the progress of research. It will be he, in the end, who will grant, or not, a marketing authorization for the product.
–
